supported by the National Key R&D Program of China(project numbers:2022YFC2305303 and 2017YFC1200303).
Background Seroprevalence studies across various countries can contribute to achieving the elimination target for measles and rubella.However,in the Mainland of China,the concept of herd immunity remains unclear due t...
Supported by the operation of the public health emergency response mechanism of the Chinese Center for Disease Control and Prevention(No.102393220020010000017);the World Health Organization Rubella and Congenital Rubella Syndrome Surveillance Program(No.601007).
Background:Since rubella was incorporated into the national disease surveillance system in 2004,rubella incidence has changed dramatically.This study analyzed the impact of immunization strategies on the age-specific ...
Objective To analyze the epidemiological characteristics of measles,mumps,and rubella(MMR)between 2014 and 2021 and identify potential strategies and measures for the prevention and control of MMR in China.Methods Dat...
supported by National Natural Science Foundation of China grants (31925004);the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB27010305);K.C.Wong Education Foundation (GJTD-2020-05).
Transposable elements(TEs)are prevalent components of diverse genomes,and play an important role on the genomic stability and expression regulation of their adjacent genes.It is interesting to know the variation of TE...
Objective:To describe the situation of measles in Sri Lanka from May to November,2023 and to define the role of virology laboratory towards case confirmation and epidemiological and genetic characterization of the out...
Background Chemotherapy and hematopoietic stem cell transplantation(HSCT)can damage the immune system,and may result in a loss of protection from infectious diseases.This study aimed to evaluate the impact of these tr...
Sero-positivity rates of the rubella virus among pregnant women vary from country to country widely throughout the world. In the Central African Republic, rubella vaccination is not included in the national immunizati...
Since 1814,when rubella was first described,the origins of the disease and its causative agent,rubella virus(Matonaviridae:Rubivirus),have remained unclear1.Here we describe ruhugu virus and rustrela virus in Africa a...
Supported by the National Natural Science Foundation of China(No.81072896);Young Scientists Fund of the National Natural Science Foundation of China(No.81704198)
Objective: To analyze the correlations between the incidence of rubella and meteorological factors over the same period and previous periods including 1, 2, 3 and 4 year ago(defined according to Chinese medicine Yunqi...
A clinical trial of measles and rubella combined vaccine (MR: MRVAC) produced by POLYVAC was conducted in Vietnam in 2016. A total of 756 subjects were enrolled, and 504 were allocated to MRVAC and 252 to control MR v...